Ultrasound assisted versus landmark based intrathecal administration of nusinersen in adults with spinal muscular atrophy disease: A randomized trial

Documenti analoghi

• Ultrasound‐assisted and landmark‐based nusinersen delivery in spinal muscular atrophy adults: A retrospective analysis
  di: Bruno Antonio Zanfini, et al.
  Pubblicazione: (2024)
• Transverse interlaminar ultrasound‐guided C1‐C2 puncture for the intrathecal administration of nusinersen in patients with spinal muscular atrophy
  di: Qing Yuan, et al.
  Pubblicazione: (2024)
• Safety of risdiplam in spinal muscular atrophy patients after short‐term treatment with nusinersen
  di: Yue Yan, et al.
  Pubblicazione: (2024)
• Six‐minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersen
  di: Alessandra Govoni, et al.
  Pubblicazione: (2024)
• Onasemnogene abeparvovec gene therapy for spinal muscular atrophy: A cohort study from the United Arab Emirates
  di: Vivek Mundada, et al.
  Pubblicazione: (2024)